Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

424
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
424
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

3.1K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

859
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
859
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

915
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
915
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

732
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
732

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Observation of P-odd γ Asymmetry in Polarized Neutron Capture on Hydrogen.

Physical review letters·2019
Same author

Dynamic optical coherence tomography of skin blood vessels - proposed terminology and practical guidelines.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Validation of Dynamic optical coherence tomography for non-invasive, in vivo microcirculation imaging of the skin.

Microvascular research·2016
Same author

Right hemisphere processing superiority during sustained visual attention.

Journal of cognitive neuroscience·2013
Same author

Fevers, headache and abnormal liver function in a 68-year-old man.

Journal of the Royal Society of Medicine·2010
Same author

Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.

Clinical and experimental immunology·2008

Related Experiment Video

Updated: Jan 8, 2026

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

1.5K

Argentaffin cells in ulcerative colitis.

J M Skinner, R Whitehead, J Piris

    Gut
    |August 1, 1971
    PubMed
    Summary
    This summary is machine-generated.

    Argentaffin cell counts were lower in ulcerative colitis patients compared to controls. This reduction in rectal argentaffin cells was not linked to inflammation severity or illness duration in ulcerative colitis.

    More Related Videos

    Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
    07:05

    Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

    Published on: December 15, 2017

    8.7K
    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
    08:58

    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

    Published on: January 5, 2017

    12.7K

    Related Experiment Videos

    Last Updated: Jan 8, 2026

    Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
    06:31

    Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

    Published on: June 2, 2023

    1.5K
    Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
    07:05

    Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

    Published on: December 15, 2017

    8.7K
    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
    08:58

    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

    Published on: January 5, 2017

    12.7K

    Area of Science:

    • Gastroenterology
    • Cell Biology
    • Histopathology

    Background:

    • Argentaffin cells, also known as enterochromaffin cells, play a role in gut homeostasis.
    • Alterations in neuroendocrine cells have been implicated in inflammatory bowel diseases.
    • Ulcerative colitis is a chronic inflammatory condition affecting the colon.

    Purpose of the Study:

    • To investigate the density of argentaffin cells in rectal biopsies from patients with ulcerative colitis.
    • To compare argentaffin cell numbers between ulcerative colitis patients and a healthy control group.
    • To determine if changes in argentaffin cell numbers correlate with disease severity or duration.

    Main Methods:

    • Rectal biopsies were obtained from patients diagnosed with ulcerative colitis and from a control cohort.
    • The number of argentaffin cells within the rectal epithelium was quantified using histopathological analysis.
    • Statistical methods were employed to compare cell counts between groups and assess correlations.

    Main Results:

    • A statistically significant decrease in the number of argentaffin cells was observed in the rectal epithelium of patients with ulcerative colitis compared to controls.
    • No significant correlation was found between the reduced argentaffin cell count and the severity of rectal inflammation.
    • The duration of ulcerative colitis illness did not show a relationship with the observed decrease in argentaffin cells.

    Conclusions:

    • The study demonstrates a depletion of argentaffin cells in ulcerative colitis.
    • The findings suggest that the reduction in argentaffin cells is a feature of ulcerative colitis, independent of inflammation severity or disease duration.
    • Further research is warranted to elucidate the functional implications of argentaffin cell loss in ulcerative colitis pathogenesis.